Regeneron Pharmaceuticals, Inc.

REGN

Market Cap$60.72B

Volume66.03K

Revenue$14.21B

Gross Profits$6.73B

Employees15182

EquityBiotechnologyHealthcareUSDwww.regeneron.com

About

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabeti...